Story perspectives
Solace Startup Secures $300M Valuation Amid Healthcare Dissatisfaction
3/26/2025
25 5
1 of 1
Story summary
- Solace, a healthcare startup founded in 2022, raised Series B funding led by Menlo Ventures, valuing it over $300 million.
- The company seeks to raise an additional $40 million to connect patients with healthcare advocates.
- Solace offers virtual support for over 100 conditions, now covered by Medicare.
- The startup previously secured $21 million, including $14 million in Series A funding.
- Solace's growth highlights rising public dissatisfaction with the healthcare system.
